Doctolib

Nvidia has taken a stake in Doctolib, the Berlin-based medical appointment and practice management platform used widely across Germany and France. The chipmaker's investment ties the company to digital healthcare, where its AI technology is being applied to medical services. The news, reported by heise online, is being shared with commentary on AI, digitisation and the future of digital health.

Nvidia has bought minority stakes in two French technology companies: Doctolib, a major European medical appointment booking and health software firm, and Genesis AI, a French artificial intelligence startup. The investments were reported by Reuters. The move fits Nvidia's broader strategy of backing companies that build on its chips and AI technology, and highlights growing interest in France's AI sector.

Nvidia has agreed to acquire minority stakes in four French technology startups, including medical booking platform Doctolib, as part of an effort to develop artificial intelligence tools. The investment signals Nvidia's push to expand its AI footprint in Europe and strengthen ties with local tech firms. The move is drawing attention as French startups gain backing from the world's dominant AI chipmaker.

Nvidia has announced it will invest in Doctolib, the French medical appointment and health services website. The chipmaker's chief executive said the funds will be used to accelerate hiring and the development of Doctolib's in-house AI models. The move extends Nvidia's reach into European health tech and underscores growing corporate demand for medical AI tools.

Nvidia has invested in four startups, including French medical booking platform Doctolib and robotics firm Genesis AI, according to the report. The move signals Nvidia's continued push beyond chips into backing companies across healthcare and artificial intelligence. Details on the size of the investments and the two other startups involved have not yet been disclosed.